arrow_back Trending Legislation
Share share

Down Syndrome Research Support: New Programs and Funding

The "DeOndra Dixon INCLUDE Project Act of 2024" aims to significantly boost research, training, and investigations related to Down syndrome. Citizens, especially families of individuals with Down syndrome, can expect improved medical care, new therapies, and enhanced quality of life through a better understanding of the condition and its co-occurring disorders. $90 million annually is authorized for this purpose from 2025 to 2029.
Key points
Increased funding for Down syndrome research: $90 million annually for fiscal years 2025-2029.
Development of new medical therapies and interventions, including pharmacological, for individuals with Down syndrome.
Better understanding of co-occurring conditions like Alzheimer's Disease and autoimmunity in individuals with Down syndrome.
Improved quality of life for individuals with Down syndrome and their families through targeted research and support.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
DeOndra Dixon INCLUDE Project Act of 2024
Print number: HR 7406
Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
Process start date: 2024-02-16
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Down Syndrome Research Support: New Programs and Funding

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 7406.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-02-16.

What are the main provisions?

Key points include:

  • Increased funding for Down syndrome research: $90 million annually for fiscal years 2025-2029.
  • Development of new medical therapies and interventions, including pharmacological, for individuals with Down syndrome.
  • Better understanding of co-occurring conditions like Alzheimer's Disease and autoimmunity in individuals with Down syndrome.
  • Improved quality of life for individuals with Down syndrome and their families through targeted research and support.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. McMorris Rodgers, Cathy [R-WA-5].

What is the latest detailed status?

The latest detailed status is: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5304-5305)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 7406

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Family